Fractyl Health Inc

NAS:GUTS (USA)  
$ 6.70 -0.02 (-0.3%) 10:08 PM EST
At Loss
Market Cap:
$ 320.78M
Enterprise V:
$ 374.92M
Volume:
111.79K
Avg Vol (2M):
366.47K
Volume:
111.79K
At Loss
Avg Vol (2M):
366.47K

Business Description

Compare
Compare
Traded in other countries / regions
GUTS.USA
IPO Date
2024-02-02
Description
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
Name Current Vs Industry Vs History
Cash-To-Debt 0.38
Equity-to-Asset -4.27
Debt-to-Equity -0.27
Debt-to-EBITDA -3.23
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -7.48
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 54.12
9-Day RSI 46.6
14-Day RSI 42.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.19
Quick Ratio 3.18
Cash Ratio 2.97
Days Inventory 1000.37
Days Sales Outstanding 288.6
Days Payable 9547.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 16.7
Name Current Vs Industry Vs History
Gross Margin % 37.21
Operating Margin % -62451.16
Net Margin % -81225.58
FCF Margin % -100423.26
ROA % -60.08
ROIC % -140.11
ROC (Joel Greenblatt) % -311.78
ROCE % -54.19

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 6654.18
EV-to-EBIT -13.96
EV-to-EBITDA -14.03
EV-to-Revenue 8719.16
EV-to-FCF -8.68
Earnings Yield (Greenblatt) % -7.16
FCF Yield % -13.46

Financials

GUTS's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:GUTS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Fractyl Health Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.043
EPS (TTM) ($) -0.916
Beta 0
Volatility % 0
14-Day RSI 42.8
14-Day ATR ($) 0.644889
20-Day SMA ($) 6.8925
12-1 Month Momentum % 0
52-Week Range ($) 5.7501 - 14.5
Shares Outstanding (Mil) 47.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Fractyl Health Inc Filings

Filing Date Document Date Form
No Filing Data

Fractyl Health Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Fractyl Health Inc Frequently Asked Questions

What is Fractyl Health Inc(GUTS)'s stock price today?
The current price of GUTS is $6.70. The 52 week high of GUTS is $14.50 and 52 week low is $5.75.
When is next earnings date of Fractyl Health Inc(GUTS)?
The next earnings date of Fractyl Health Inc(GUTS) is .
Does Fractyl Health Inc(GUTS) pay dividends? If so, how much?
Fractyl Health Inc(GUTS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1